1) Morales A, Lunenfeld B. Standards, guidelines and recommendations of the international society for the study of the aging male (ISSAM). Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. Aging Male. 2002; 5: 74-86
|
|
|
2) 宮川 康, 辻村 晃, 高田晋吾, 他. 男性更年期における精巣機能. Pharma Medica. 2005; 5: 25-9
|
|
|
3) 岩本晃明, 柳瀬敏彦, 高 栄哲, 他. 日本人成人男子の総テストステロン, 遊離テストステロンの基準値の設定. 日本泌尿器科学会雑誌. 2004; 95: 751-60
|
|
|
4) 内閣府. 平成19年版高齢社会白書
|
|
|
5) 日本泌尿器科学会および日本Men's Health医学会, LOH症候群診療ガイドライン作成ワーキンググループ. LOH症候群診療ガイドライン. In: 加齢男性性腺機能低下症候群(LOH症候群)診療の手引き. 東京: じほう; 2007
|
|
|
6) Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000; 49: 1239-42
|
|
|
7) Heinemann LAJ, Zimmermann T, Vermeulen A, et al. A new ‘Aging Males'Symptoms'(AMS) rating scale. Aging Male. 1999; 2: 105-14
|
|
|
8) 辻村 晃, 西村和郎, 松宮清美, 他. 男性更年期障害への関心-日本性機能学会総会でのアンケ-ト調査より. 泌尿外科. 2003; 16: 757-63
|
|
|
9) Endocrine Society 2002. Summary from the Second Annual Andropause Consensus Committee
|
|
|
10) T'Sjoen G, Goemaere S, De Meyere M, et al. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology. 2004; 29: 201-14
|
|
|
11) T'Sjoen G, Feyen E, De Kuyper P, et al. Self-referred patients in an aging male clinic: much more than androgen deficiency alone. Aging Male. 2003; 6: 157-65
|
|
|
12) Tsujimura A, Matsumiya K, Miyagawa Y, et al. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Imp Res. 2005; 17: 259-63
|
|
|
13) Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male. 2005; 8: 56-8
|
|
|